Fungal keratitis: Does antifungal Resistance Influence the outcome?
摘要
To correlate clinical outcomes of fungal keratitis with in vitro antifungal susceptibility profiles.
MethodsThis retrospective case series included microbiologically confirmed fungal keratitis cases treated with antifungals for ≥ 1 week (August–December 2022). Cases with early therapeutic penetrating keratoplasty (TPK) (< 1 week) or mixed etiology were excluded.
ResultsRecords of 83 patients were reviewed. Medical cure was achieved in 48 (57.8%) patients, while 35 (42.2%) underwent TPK. Fusarium sp.(41%) and Aspergillus sp.(33.7%) were most prevalent. Several other fungi were isolated like Curvularia, Acremonium, Lasiodiplodia, etc. (25.3%). Fusarium showed lower natamycin resistance (35.3%) than Aspergillus (50%) (p = 0.2429) species; but higher resistance to voriconazole, itraconazole, and posaconazole (V, 82.4%; I, 66.7%; P, 82.4%) versus Aspergillus (V, 39.3%; I, 26.9%; P, 32.1%) (p < 0.005). Among cases with milder severity (infiltrate < 4 mm) (n = 40), higher natamycin resistance was associated with greater rate of TPK (60%) versus medical resolution (26.7%) (p = 0.123).
ConclusionAlthough the outcomes are multifactorial, antifungal resistance seems to influence the prognosis of fungal keratitis.